Table 1.
Variable | N |
---|---|
Age | |
Diagnosis | 7.77 years (1.29–17.52) |
At start of radiation therapy | 8.98 years (3.20–17.63) |
Presentation | |
Headache | 62 |
Visual disturbance | 17 |
Growth delay | 9 |
Emesis | 4 |
Loss of consciousness | 4 |
Head injury | 3 |
Precocious puberty | 2 |
Gender | |
Female | 46 |
Male | 55 |
Race | |
Asian/Pacific islander | 1 |
Black | 22 |
Hispanic | 2 |
White | 76 |
Extraventricular drain | |
Yes | 23 |
No | 78 |
CSF shunt | |
Yes | 27 |
No | 74 |
CTV margin | |
≤0.5 cm | 76 |
1.0 cm | 25 |
PTV margin | |
0.3 cm | 58 |
0.5 cm | 43 |
Dose | |
54Gy | 94 |
55.8Gy | 7 |
Target volumes (mL) | |
GTV | 12.28(0.42–64.66) |
CTV | 36.84 (5.20–176.7) |
PTV | 65.75 (17.31–257.5) |
Target volume dose coverage (cGy) | |
D95GTV | 5441 (5298–5740) |
D95CTV | 5415 (5031–5701) |
D95PTV | 5364 (5347–5691) |
Planning and delivery method | |
Conformal radiation therapy | 84 |
Intensity-modulated radiation therapy | 17 |
Abbreviations: CSF, cerebrospinal fluid; CTV, clinical target volume; PTV, planning target volume; GTV, gross total volume.